Oral hypoglycemic drugs (such as metformin, sulfonylureas, α‐glucosidase inhibitors, and glinides) and insulin therapy are the main clinical treatments that are used to regulate blood sugar and relieve the symptoms of T2DM (Aschner, 2020; Dowarah & Singh, 2020; Lv et al., 2020; Sanchez‐Rangel & Inzucchi, 2017). This evidence concerns the gene INS and type 2 diabetes mellitus.